Citations

Clear

4847 citation(s) found for "Yu, Eric".

Non-alcoholic fatty liver disease-associated hepatocellular carcinoma: effect of hepatic steatosis on major hepatocellular carcinoma features at MRI
Thompson, Scott M. , Garg, Ishan , Ehman, Eric C. , Sheedy, Shannon P. , Bookwalter, Candice A., Carter, Rickey E. , Roberts, Lewis R. , Venkatesh, Sudhakar K. , Roberts, Lewis R , Carter, Rickey E , Venkatesh, Sudhakar K , Thompson, Scott

Mayo Clinic

The British Journal of Radiology | August 3, 2018 | Volume: 91 | Issue: 1092 | Pages: No page available

10.1259/bjr.20180345 | PMID 30074820 Get It

Objective: To evaluate the effect of hepatic steatosis on LI-RADS® major features at MRI in patients with non-alcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC). Methods: HCC and liver parenchyma features at MRI from 48 consecutive patients with NAFLD and histology proven HCC (mean ± SD; 4.5 ± 3.4 cm) were independently reviewed by three radiologists. Inter-rater agreement was determined by prevalence/bias-adjusted kappa. Hepatic fat signal fraction (FS%) was independently calculated. HCC features were compared by FS% at MRI using logistic regression analysis and histologic steatosis grade using Cochran-Armitage test for trend, stratified by cirrhotic liver morphology or histologic fibrosis stage. Receiver operating characteristic curves were generated to determine the sensitivity and specificity for major HCC features by FS%. Results: Major HCC features included arterial phase hyperenhancement (APHE) in 45 (93%), portal venous phase washout (PVWO) in 30 (63%), delayed phase washout (DPWO) in 38 (79%) and enhancing “capsule” in 34 (71%). Cirrhotic morphology was present in 22 (46%). Inter-rater agreement was 0.75 for APHE, 0.42–0.58 for PVWO, 0.58–0.71 for DPWO and 0.38–0.67 for enhancing “capsule”. There was an 18%, 14% and 22% increase in the odds of absent PVWO, DPWO and capsule appearance for every 1% increase in hepatic FS% in patients with non-cirrhotic liver morphology (p = 0.011, 0.040 and 0.029, respectively). Hepatic FS% ≥ 14.8% had a sensitivity and specificity of 64 and 100% for absent PVWO and 71 and 90% for absent DPWO in patients with non-cirrhotic liver morphology. Conclusion: Absent washout and capsule appearance are associated with increasing hepatic steatosis in patients with non-cirrhotic, NAFLD-associated HCC. Advances in knowledge: In patients with non-cirrhotic, non-alcoholic fatty liver disease (NAFLD)-associated hepatocellular carcinoma (HCC), absent HCC washout and capsule appearance are associated with increasing hepatic steatosis, thereby potentially impacting the noninvasive imaging diagnosis of HCC in these patients. Lack of washout or capsule appearance in steatotic livers at MRI may require alternative criteria for the diagnosis of HCC in patients with non-cirrhotic NAFLD.
A Randomized Single‐Blinded Trial of Posttonsillectomy Liposomal Bupivacaine among Adult Patients
Olson, Michael D. , Moore, Eric J. , Price, Daniel L.

Mayo Clinic

Otolaryngology–Head and Neck Surgery | July 31, 2018 | Volume: 159 | Issue: 5 | Pages: 835-842

10.1177/0194599818791773 | PMID 30060719 Get It

ObjectiveTo determine whether liposomal bupivacaine (Exparel) is safe and effective in the management of posttonsillectomy pain among adult patients.Study DesignA prospective single‐blind randomized controlled trial.SettingAn academic quaternary care center (Mayo Clinic, Rochester, Minnesota).Subjects and MethodsFrom May 2015 to December 2016, 39 patients were randomized to receive oral pain medication and 8 mL of injected liposomal bupivacaine or oral pain medication alone for treatment of their posttonsillectomy pain. Visual analog scale pain intensity scores, oral pain medication usage, liquid oral intake, and complications were recorded for 2 weeks after the procedure.ResultsThirty‐nine patients were randomized, with 17 patients in the liposomal bupivacaine group and 22 in the control group. Fifteen patients in the liposomal bupivacaine group and 18 patients in the control group completed the study. Pain intensity score on postoperative day 1 (P =. 043) proved to be the only statistically significant result, with no difference noted in pain scores on postoperative days 2 to 14. There was no difference in pain medication usage, liquid oral intake, postoperative hemorrhage, or adverse events between groups.ConclusionsThe injection of liposomal bupivacaine in the posttonsillectomy wound bed demonstrates improved pain intensity scores for the first 24 hours after surgery with no adverse complications noted in comparison with patients who did not receive the injection. Given the limited pain reduction and increased cost, use of liposomal bupivacaine in adult tonsillectomy patients appears to have minimal indication for use.
Multigene Hereditary Cancer Panels Reveal High-Risk Pancreatic Cancer Susceptibility Genes
Hu, Chunling , LaDuca, Holly , Lilyquist, Jenna , Thomas, Abigail, Davis, Brigette Tippin, Black, Mary Helen , Pesaran, Tina , Goldgar, David E. , Dolinsky, Jill S. , Shimelis, Hermela , Polley, Eric C. , Hart, Steven N. , Na, Jie , Lee, Kun Y. , Hu, Chunling , Couch, Fergus J.

Mayo Clinic

JCO Precision Oncology | July 25, 2018 | Volume: No volume available | Issue: 2 | Pages: 1-28

10.1200/po.17.00291 | PMID 31497750 Get It

Purpose The relevance of inherited pathogenic mutations in cancer predisposition genes in pancreatic cancer is not well understood. We aimed to assess the characteristics of patients with pancreatic cancer referred for hereditary cancer genetic testing and to estimate the risk of pancreatic cancer associated with mutations in panel-based cancer predisposition genes in this high-risk population. Methods Patients with pancreatic cancer (N = 1,652) were identified from a 140,000-patient cohort undergoing multigene panel testing of predisposition genes between March 2012 and June 2016. Gene-level mutation frequencies relative to Exome Aggregation Consortium and Genome Aggregation Database reference controls were assessed. Results The frequency of germline cancer predisposition gene mutations among patients with pancreatic cancer was 20.73%. Mutations in ATM, BRCA2, CDKN2A, MSH2, MSH6, PALB2, and TP53 were associated with high pancreatic cancer risk (odds ratio, > 5), and mutations in BRCA1 were associated with moderate risk (odds ratio, > 2). In a logistic regression model adjusted for age at diagnosis and family history of cancer, ATM and BRCA2 mutations were associated with personal history of breast or pancreatic cancer, whereas PALB2 mutations were associated with family history of breast or pancreatic cancer. Conclusion These findings provide insight into the spectrum of mutations expected in patients with pancreatic cancer referred for cancer predisposition testing. Mutations in eight genes confer high or moderate risk of pancreatic cancer and may prove useful for risk assessment for pancreatic and other cancers. Family and personal histories of breast cancer are strong predictors of germline mutations.
Exercise Stroke Volume in Adult Cystic Fibrosis: A Comparison of Acetylene Pulmonary Uptake and Oxygen Pulse
Iterson, Erik H. Van , Baker, Sarah E. , Wheatley, Courtney M. , Olson, Thomas P. , Snyder, Eric M., Van Iterson, Erik H , Baker, Sarah E , Morgan, Wayne J.

Mayo Clinic

Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine | July 25, 2018 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/1179548418790564 | PMID 30083061 Get It

Cardiac hemodynamic assessment during cardiopulmonary exercise testing (CPET) is proposed to play an important role in the clinical evaluation of individuals with cystic fibrosis (CF). Cardiac catheterization is not practical for routine clinical CPET. Use of oxygen pulse (O 2 pulse) as a noninvasive estimate of stroke volume (SV) has not been validated in CF. This study tested the hypothesis that peak exercise O 2 pulse is a valid estimate of SV in CF. Measurements of SV via the acetylene rebreathe technique were acquired at baseline and peak exercise in 17 mild-to-moderate severity adult CF and 25 age-matched healthy adults. We calculated [Formula: see text]. Baseline relationships between SV and O 2 pulse were significant in CF ( r = .80) and controls ( r = .40), persisting to peak exercise in CF ( r = .63) and controls ( r = .73). The standard error of estimate for O 2 pulse-predicted SV with respect to measured SV was similar at baseline (14.1 vs 20.1 mL) and peak exercise (18.2 vs 13.9 mL) for CF and controls, respectively. These data suggest that peak exercise O 2 pulse is a valid estimate of SV in CF. The ability to noninvasively estimate SV via O 2 pulse during routine clinical CPET can be used to improve test interpretation and advance our understanding of the impact cardiac dysfunction has on exercise intolerance in CF.
MULTIMODAL IMAGING OF CHOROIDAL AND OPTIC DISK VESSELS NEAR OPTIC DISK PITS
Adams, Matthew K., Cohen, Salomon Y. , Souied, Eric H., Goldenberg, Dafna, Olsen, Timothy W. , Pulido, José S. , Souied, Eric H. , Loewenstein, Anat

Mayo Clinic

RETINAL Cases & Brief Reports | July 25, 2018 | Volume: 14 | Issue: 4 | Pages: 289-296

10.1097/icb.0000000000000765 | PMID 30045152 Get It

Purpose: To describe modern multimodal imaging of the choroidal and optic disk vessels in optic disk pits. Methods: Case reports of four patients with optic disk pit who underwent multimodal imaging of the optic pit and surrounding structures. Patients included in this article were found to have optic disk pits and subsequently underwent multimodal imaging. Results: Cilioretinal arteries were present in two of the four cases (50%). SPECTRALIS optical coherence tomography showed intraretinal and subretinal fluid in all cases. Small vessels in the choroid and in the disk around the pit were also present in all cases through optical coherence tomographic angiography. Confocal fluorescein angiographic imaging in the first case showed leakage from the vessels adjacent to the optic disk pit. Conclusion: Modern multimodal imaging shows that there are anomalous vessels in and around an optic pit. Whether these vessels affect the development of optic pit, maculopathy needs to be further evaluated.
Impact of the SPOP Mutant Subtype on the Interpretation of Clinical Parameters in Prostate Cancer
Liu, Deli , Takhar, Mandeep, Alshalalfa, Mohammed , Erho, Nicholas , Shoag, Jonathan E. , Jenkins, Robert B. , Karnes, R. Jeffrey , Ross, Ashley E. , Schaeffer, Edward M. , Rubin, Mark A. , Klein, Eric A. , Tomlins, Scott A. , Spratt, Daniel E. , Spratt, Daniel E , Klein, Eric A , Trock, Bruce J , Den, Robert B. , Davicioni, Elai , Sboner, Andrea , Barbieri, Christopher , Rubin, Mark A

Mayo Clinic

JCO Precision Oncology | July 24, 2018 | Volume: No volume available | Issue: 2 | Pages: 1-13

10.1200/po.18.00036 | PMID 30761387 Get It

Purpose Molecular characterization of prostate cancer, including The Cancer Genome Atlas, has revealed distinct subtypes with underlying genomic alterations. One of these core subtypes, SPOP (speckle-type POZ protein) mutant prostate cancer, has previously only been identifiable via DNA sequencing, which has made the impact on prognosis and routinely used risk stratification parameters unclear. Methods We have developed a novel gene expression signature, classifier (Subclass Predictor Based on Transcriptional Data), and decision tree to predict the SPOP mutant subclass from RNA gene expression data and classify common prostate cancer molecular subtypes. We then validated and further interrogated the association of prostate cancer molecular subtypes with pathologic and clinical outcomes in retrospective and prospective cohorts of 8,158 patients. Results The subclass predictor based on transcriptional data model showed high sensitivity and specificity in multiple cohorts across both RNA sequencing and microarray gene expression platforms. We predicted approximately 8% to 9% of cases to be SPOP mutant from both retrospective and prospective cohorts. We found that the SPOP mutant subclass was associated with lower frequency of positive margins, extraprostatic extension, and seminal vesicle invasion at prostatectomy; however, SPOP mutant cancers were associated with higher pretreatment serum prostate-specific antigen (PSA). The association between SPOP mutant status and higher PSA level was validated in three independent cohorts. Despite high pretreatment PSA, the SPOP mutant subtype was associated with a favorable prognosis with improved metastasis-free survival, particularly in patients with high-risk preoperative PSA levels. Conclusion Using a novel gene expression model and a decision tree algorithm to define prostate cancer molecular subclasses, we found that the SPOP mutant subclass is associated with higher preoperative PSA, less adverse pathologic features, and favorable prognosis. These findings suggest a paradigm in which the interpretation of common risk stratification parameters, particularly PSA, may be influenced by the underlying molecular subtype of prostate cancer.
CDKN2AGermline Rare Coding Variants and Risk of Pancreatic Cancer in Minority Populations
Wieben, Eric D. , Chaffee, Kari G. , Antwi, Samuel O. , Olopade, Olufunmilayo I. , Li, Donghui , Highsmith, W. Edward, Colón‐Otero, Gerardo , Khanna, Lauren , Frucht, Harold, Blot, William J. , Wu, Lang , Almada, Luciana L. , Fernández-Zapico, Martín E. , Sicotte, Hugues , Pedersen, Katrina S. , Petersen, Gloria M. , Rabe, Kari G. , McWilliams, Robert R. , Raskin, Leon , Li, Donghui , Permuth, Jennifer B , Sicotte, Hugues , Antwi, Samuel O , Olopade, Olufunmilayo I , Pedersen, Katrina , Permuth, Jennifer B. , Olson, Janet E. , Genkinger, Jeanine M. , Zheng, Wei

Mayo Clinic

Cancer Epidemiology, Biomarkers & Prevention | July 23, 2018 | Volume: 27 | Issue: 11 | Pages: 1364-1370

10.1158/1055-9965.epi-17-1065 | PMID 30038052 Get It

AbstractBackground: Pathogenic germline mutations in the CDKN2A tumor suppressor gene are rare and associated with highly penetrant familial melanoma and pancreatic cancer in non-Hispanic whites (NHW). To date, the prevalence and impact of CDKN2A rare coding variants (RCV) in racial minority groups remain poorly characterized. We examined the role of CDKN2A RCVs on the risk of pancreatic cancer among minority subjects.Methods: We sequenced CDKN2A in 220 African American (AA) pancreatic cancer cases, 900 noncancer AA controls, and 183 Nigerian controls. RCV frequencies were determined for each group and compared with that of 1,537 NHW patients with pancreatic cancer. Odds ratios (OR) and 95% confidence intervals (CI) were calculated for both a case–case comparison of RCV frequencies in AAs versus NHWs, and case–control comparison between AA cases versus noncancer AA controls plus Nigerian controls. Smaller sets of Hispanic and Native American cases and controls also were sequenced.Results: One novel missense RCV and one novel frameshift RCV were found among AA patients: 400G>A and 258_278del. RCV carrier status was associated with increased risk of pancreatic cancer among AA cases (11/220; OR, 3.3; 95% CI, 1.5–7.1; P = 0.004) compared with AA and Nigerian controls (17/1,083). Further, AA cases had higher frequency of RCVs: 5.0% (OR, 13.4; 95% CI, 4.9–36.7; P < 0.001) compared with NHW cases (0.4%).Conclusions: CDKN2A RCVs are more common in AA than in NHW patients with pancreatic cancer and associated with moderately increased pancreatic cancer risk among AAs.Impact: RCVs in CDKN2A are frequent in AAs and are associated with risk for pancreatic cancer. Cancer Epidemiol Biomarkers Prev; 27(11); 1364–70. ©2018 AACR.
Hearing Outcomes in Conservatively Managed Vestibular Schwannoma Patients With Serviceable Hearing
Hunter, Jacob B. , Dowling, Eric M. , Lohse, Christine M. , O’Connell, Brendan P., Tombers, Nicole M. , Lees, Katherine A. , Thompson, Reid, Haynes, David S. , Carlson, Matthew L. , Dowling, Eric M., Hunter, Jacob B

Mayo Clinic

Otology & Neurotology | July 23, 2018 | Volume: 39 | Issue: 8 | Pages: e704-e711

10.1097/mao.0000000000001914 | PMID 30036205 Get It

Objective: To characterize the risk of progression to nonserviceable hearing in patients with sporadic vestibular schwannomas (VS) who elect initial observation. Study Design: Retrospective case series. Setting: Two tertiary care centers. Patients: VS patients with serviceable hearing who underwent at least two audiograms and two MRI studies before intervention or loss to follow-up. Main outcome measure(s): Serviceable hearing, defined as the pure tone average ≤ 50 dB HL and word recognition score ≥ 50%. Results: Four-hundred sixty-six patients (median age of 57 yr and median tumor diameter of 7.3 mm) had serviceable hearing at presentation and were followed for a median of 2.3 years (IQR 1.0 – 4.0). Kaplan–Meier estimated rates of maintaining serviceable hearing (95% CI; number still at risk) at 1, 3, 5, 7, and 10 years following diagnosis were 94% (91–96; 357), 77% (73–82; 172), 66% (60–73; 81), 56% (49–65; 31), and 44% (33–59; 10), respectively. Each 10-dB increase in pure-tone averages at diagnosis was associated with a 2-fold increased likelihood of developing nonserviceable hearing (hazard ratio 2.07; p < 0.001). Each 10% decrease in word recognition score was associated with a 1.5-fold increased likelihood of developing nonserviceable hearing (hazard ratio 1.48; p < 0.001). Conclusions: Among patients with sporadic VS, good baseline word recognition score and low pure-tone average are jointly associated with maintenance of serviceable hearing. These data may be used to guide patient counseling and optimize management.
Fuchs' Endothelial Corneal Dystrophy in Patients With Myotonic Dystrophy, Type 1
Winkler, Nelson S., Milone, Margherita , Martinez‐Thompson, Jennifer M. , Raja, Harish, Aleff, Ross A., Fautsch, Michael P. , Wieben, Eric D. , Baratz, Keith H. , Patel, Sanjay V.

Mayo Clinic

Investigative Opthalmology & Visual Science | July 20, 2018 | Volume: 59 | Issue: 7 | Pages: 3053

10.1167/iovs.17-23160 | PMID 30025114 Get It